[mwai_chatbot id="default" stream="1" typing="1"]
Screen billions of compounds to accelerate hit discovery.

DNA-Encoded library (DEL)

BioDuro and X-Chem combine industry-leading DNA-encoded library (DEL) technology, advanced protein screening, and data-driven hit identification to help discovery teams rapidly identify novel starting points across challenging target classes.

Partner with us
0
+
DEL Discovery Programs Delivered
0
+
Validated Hit Compounds Identified
0
+
Target Classes Screened
Billions
of DNA-Encoded Compounds Available for Screening
More information?
Contact us

Designed for Efficient Hit Discovery

DNA-encoded library screening combines large-scale chemical diversity with advanced selection technologies to identify novel binders and accelerate early discovery programs.

Explore vast chemical space

Extensive DEL Libraries

Lead-like and drug-like DNA-encoded libraries designed to maximize screening diversity while maintaining developable chemical matter.

Generate actionable hit data

Advanced Screening & Analysis

Comprehensive protein quality control, DEL selection workflows, and AI-powered data analysis help identify and prioritize promising hits.

Move beyond hit identification

Discovery Advancement

Chemistry, biology, pharmacology, and DMPK expertise help advance validated hits toward lead optimization and candidate discovery.

Accelerating Hit Discovery Through Large-Scale Screening

DNA-encoded library (DEL) technology enables the rapid screening of billions of compounds against challenging biological targets, helping discovery teams identify novel binders and generate high-quality starting points for drug discovery programs.

BioDuro’s DEL screening platform combines advanced library design, protein quality control, selection workflows, and data analysis to support efficient hit identification and prioritization.

High-Quality DEL Libraries

Focused lead-like and drug-like libraries designed to maximize chemical diversity while maintaining relevance for downstream drug discovery.

Comprehensive Screening & Analysis

Protein quality control, DEL selection workflows, and AI-powered analysis help identify enriched binders and prioritize promising hit series.

Actionable Hit Information

Hit structures are delivered with embedded SAR insights to support rapid follow-up chemistry and informed decision-making.

Flexible Partnership Model

Transparent project structures with full freedom to operate and no downstream financial obligations.

Related Resources

Explore how BioDuro’s Peptide DNA-Encoded Library (DEL) platform expands peptide discovery through diverse library architectures, extensive unnatural amino acid incorporation, advanced cyclization strategies, and Direct-to-Biology (D2B) workflows. This resource provides a deeper look at the technologies, screening approaches, and discovery workflows used to accelerate hit identification and peptide lead optimization.

See all resources
Peptide del screening cover image
February 8, 2026 Article Chemistry

BioDuro Advances DNA-Encoded Peptide Libraries: 108-Channel Automation Enables 10-mer+ DNA-Encoded Macrocycles for High-Throughput Drug Discovery

DNA-encoded library (DEL) technology has emerged as a powerful alternative to traditional phage and mRNA display methods for high-throughput peptide discovery. ...
Next generation of peptide drug discovery: a conversation on peptide dna encoded library platform
April 14, 2026 Article Chemistry

Next Generation of Peptide Drug Discovery: A Conversation on Peptide DNA-Encoded Library Platform

The industry is moving beyond volume-driven metrics. While phage and mRNA display achieve large library sizes, they rely on biological translation systems and f...
Peptide DNA encoded library (DEL) discovery platform
Flyer Chemistry

Peptide DNA-Encoded Library (DEL) Discovery Platform

Highlights BioDuro's Peptide DNA-Encoded Library platform, enabling rapid peptide hit discovery with vast library diversity and accelerated Direct-to-Biolo...

Ready to Accelerate Hit Discovery?

Leverage industry-leading DNA-encoded library (DEL) technology, advanced screening workflows, and integrated discovery expertise to identify novel binders and generate high-quality starting points for your drug discovery program.

Partner with us